The microbial flora of clinically infected cutaneous metastases: a retrospective study

C A Virgen1, C A Barker2, M E Lacouture3

  • 1Department of Dermatology, University of California Irvine, Irvine, USA.

Insights

Symptomatic skin metastases often harbor bacteria, with Staphylococcus aureus and Pseudomonas aeruginosa being common. Oral antibiotics significantly improved infectious symptoms in patients with cutaneous metastases.

Area of Science:

  • Oncology
  • Dermatology
  • Microbiology

Background:

  • Symptomatic cutaneous metastases can cause discharge, odor, itching, and pain, negatively impacting patient quality of life.
  • The microbial flora of skin lesions in patients with cutaneous metastases is not well-characterized.
  • Understanding microbial composition and antimicrobial treatment efficacy is crucial for managing these symptoms.

Purpose of the Study:

  • To characterize the microbial flora of cutaneous metastases.
  • To evaluate the effectiveness of antimicrobial management for symptomatic skin lesions.
  • To identify potential therapeutic strategies for infected cutaneous metastases.

Main Methods:

  • Retrospective chart review of 64 patients with cutaneous metastases referred to a Dermatology Service.
  • Microbial flora analysis of skin lesions.
  • Assessment of antimicrobial treatments, including oral and topical antibiotics.

Main Results:

  • Pathogenic and/or opportunistic bacteria were detected in 50% of skin lesions.
  • Staphylococcus aureus and Pseudomonas aeruginosa were the most frequently isolated organisms.
  • Patients receiving oral antibiotics showed statistically significant improvement in infectious symptoms compared to those not treated with oral antibiotics.

Conclusions:

  • The normal skin microbial flora is disrupted in patients with symptomatic cutaneous metastases.
  • Oral antibiotics may be beneficial as a first-line therapy for infected skin lesions in this patient population.
  • Targeted antimicrobial therapy can improve symptoms and quality of life for patients with cutaneous metastases.